🔔 After the Bell
🎯 Session Review
Markets kicked off the week in a good mood, with all three major indexes finishing in the green. The Nasdaq led the charge, jumping 1.05% to 27,477.31, while the S&P 500 added 0.66% to close at 7,773.95 and the Dow managed a more modest 0.18% gain.The real fireworks happened in healthcare and biotech, where a flurry of deals, drug approvals, and trial results sent individual names soaring. When a sector this large starts popping, it tends to pull the broader tape along for the ride.
Treasury yields ticked slightly higher across the curve, with the 10-year at 5.31%, while the dollar index slipped to 102.14. Bitcoin, meanwhile, drifted lower by 0.90% to about $85,705.
📊 Today's Market Movers
|
▲ Gainers
|
▼ Losers
|
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🚀 Key Catalysts
Biotech was the headline act. Alector shares rocketed roughly 72% in premarket trading after Roche agreed to license its experimental Parkinson's therapy in a deal worth up to $1.27 billion. Vaxcyte also had a banner day, surging 57% after its pneumococcal vaccine matched rivals in a late-stage study.Big Pharma kept the momentum going. AbbVie and Genmab reported their blood cancer combo lowered the risk of disease progression in a late-stage lymphoma study, while Eli Lilly scored an FDA orphan drug designation for its pancreatic cancer treatment olomorasib. AstraZeneca added to the upbeat tone with plans to invest over $1 billion in Massachusetts.
Defense also got a boost after Boeing landed a contract worth up to $14.7 billion from Lockheed Martin to scale up PAC-3 MSE seeker production.
Sponsored Content
AI Pioneer Issues Urgent Warning
A pioneer who spent $17 million building AI-powered market tools — part of a platform used by 180,000 people worldwide — is stepping forward with an urgent warning. He says the biggest AI stocks are about to become the market's biggest losers, and he's identified where the real money will flow next.
🎭 Investor Mood
Investor Pulse: Biotech Buzz
Investors walked in optimistic, and the news flow gave them plenty of reasons to stay that way. The combination of M&A activity, successful trials, and fresh capital investment painted a picture of a market where companies are confident enough to write big checks.That risk appetite showed up in the trending names too. Taiwan Semiconductor climbed to 485.91, PTC jumped more than 48 points, and Brazilian names like Nu Holdings rode a wave as Brazilian stocks jumped on election results with Flávio Bolsonaro becoming a favorite ahead of the October 25 runoff.
Not everything was sunshine. Lennar slipped nearly $5.40, a reminder that housing-sensitive names remain cautious with yields still sitting above 5%.
🔍 5 Focus Points for Tomorrow
| 🤖 | Follow-through in biotech after the Roche-Alector and Vaxcyte pops |
| 📊 | AbbVie and Lilly updates as oncology catalysts keep stacking up |
| 📊 | Defense names after Boeing's $14.7 billion PAC-3 contract win |
| 🏛️ | The 10-year Treasury yield holding above 5.3% and its drag on housing |
| 📊 | Brazil election runoff on October 25 and its effect on EWZ and Nu Holdings |
Sponsored Content
Buffett's Final Warning: "The Dollar Is Going to Hell"
If you have $50k+ exposed to the dollar (401(k), stocks, real estate, savings), pay attention. On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." The man who defended it for 60 years just told you it's done. Ray Dalio agrees. He calls it a "debt death spiral." $38.4 trillion in debt. JPMorgan warns we're at 120% debt-to-GDP. Greece collapsed at 130%. There's an asset class built to thrive when the dollar breaks.
💸 Bottom Line
Today was a textbook example of how a single sector can set the tone for an entire session. Biotech catalysts tend to cluster, and when deals, approvals, and trial wins all land on the same Monday, the enthusiasm spreads fast.The question now is whether this momentum has legs or whether it was a one-day sugar rush. With Treasury yields creeping higher and the housing group lagging, there are still crosscurrents worth respecting beneath the surface.
Keep an eye on the Paramount and Warner Bros situation as leadership for the combined Skydance entity takes shape, and watch the Brazil runoff on October 25, which could keep emerging market names volatile in the weeks ahead.
📰 Further Reading
Trump’s New AI Tirade Hurting GOP? (Ad)
President Trump recently said AI will not be stopped by brilliantly run destructive forces. And that it will be the greatest economic development engine in history. All while the GOP tries to curb concerns about AI ahead of the midterm elections. This divide is one reason why Whitney Tilson believes...
He's sharing his full analysis free, here.
Trump's New Dollar (Ad)
President Trump is quietly replacing the U.S. dollar, not with crypto, but something already signed and sealed by executive order. When America last reset its money under Nixon, it created one of the greatest wealth divides in history, minting thousands of new millionaires while others fell behind....
Which side will you be on?
ALERT: Drop These 5 Stocks Before The Market Opens Tomorrow (Ad)
Weiss Ratings has identified five stocks sitting in millions of portfolios right now that could get crushed by a radical market shift hitting in early 2026. Some of America's most popular names are on this list. If you own any of them, holding on could mean serious losses. The window to check your p...
Click here now — before it's too late.